Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Identifying the Role of A20 in Mitophagy and the Etiology of Parkinson's Disease

EF 2014-15

Résumé
Parkinson's disease (PD) affects an estimated 1,000 for every 100,000 Canadians aged 70 to 79, and is among the top ten leading causes of death for those aged 75 to 84. PD is characterized by the loss of dopaminergic neurons in the brain, resulting in tremors, rigidity, slowed movement and loss of balance. Dysfunctions in the process of mitophagy, that is, the degradation of damaged mitochondria within the cell, have been implicated in the etiology of PD. Mitochondria are dynamic organelles responsible for energy production and homeostasis within the cell. Interestingly, members of a family of enzymes which counteract the tagging of proteins for degradation have recently been shown to also antagonize mitophagy. We hypothesize that these enzymes regulate mitophagy and will be part of the etiology of PD. We have recently conducted preliminary research determining which members of this enzyme group localize to the mitochondria. From this, my work will involve defining the role of A20 in the process of mitophagy. I will determine how the enzymatic activities of A20 affect mitophagy, and identify the substrates of A20 involved. In short, my proposed work will delineate the role of A20 in mitochondrial turnover, and its place in the etiology of PD. Current therapeutics for PD, such as dopamine analogues, provide relief but are associated with unfavourable side effects. Research is focused on discovering new drug targets (notably enzymes) to develop better therapeutics and delay PD onset and progression. Ultimately, my work will advance the preliminary molecular research necessary to develop new treatments for Parkinson's disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331580
Name
Barras Eliane
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identifying the Role of A20 in Mitophagy and the Etiology of Parkinson's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
A20; Biochemistry; Cell Biology; Deubiquitinating Enzyme; Mitophagy; Parkin; Parkinson'S Disease; Pink1; Tnfaip3
Abstract
Parkinson's disease (PD) affects an estimated 1,000 for every 100,000 Canadians aged 70 to 79, and is among the top ten leading causes of death for those aged 75 to 84. PD is characterized by the loss of dopaminergic neurons in the brain, resulting in tremors, rigidity, slowed movement and loss of balance. Dysfunctions in the process of mitophagy, that is, the degradation of damaged mitochondria within the cell, have been implicated in the etiology of PD. Mitochondria are dynamic organelles responsible for energy production and homeostasis within the cell. Interestingly, members of a family of enzymes which counteract the tagging of proteins for degradation have recently been shown to also antagonize mitophagy. We hypothesize that these enzymes regulate mitophagy and will be part of the etiology of PD. We have recently conducted preliminary research determining which members of this enzyme group localize to the mitochondria. From this, my work will involve defining the role of A20 in the process of mitophagy. I will determine how the enzymatic activities of A20 affect mitophagy, and identify the substrates of A20 involved. In short, my proposed work will delineate the role of A20 in mitochondrial turnover, and its place in the etiology of PD. Current therapeutics for PD, such as dopamine analogues, provide relief but are associated with unfavourable side effects. Research is focused on discovering new drug targets (notably enzymes) to develop better therapeutics and delay PD onset and progression. Ultimately, my work will advance the preliminary molecular research necessary to develop new treatments for Parkinson's disease.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Barras, Eliane
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~